Natco's generic Copaxone - >I would wager that MNTA thinks it [Natco] does not [has what it takes to get a complex mixture such as Copaxone approved as a generic in the US and EU]<
I bet Teva thinks so too. Teva doesn't sell Copaxone in India but it has already initiated litigation in India against Natco. Will be interesting to see who will file first, trigger litigation and an automatic 30-month stay.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.